vchal / Shutterstock.com
14 November 2019EuropeRory O'Neill
Merck and Evotec strike CRISPR licensing deal
Merck has agreed to license its CRISPR gene-editing technology to German biotech company Evotec.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Americas
23 July 2019 Merck KGaA-owned Sigma-Aldrich has petitioned the US Patent and Trademark Office to open an interference proceeding between its own pending CRISPR-Cas9 patents and patents awarded to the University of California, Berkeley.
Big Pharma
21 November 2019 A German individual has lost an appeal before the tribunal of the EU General Court, after his trademark registration was opposed by Merck.
Americas
14 April 2020 The US International Trade Commission is investigating ‘grey market’ in vitro fertilisation products intended for the Turkish market, following a trademark complaint from German pharmaceutical company Merck KGaA.
Editor's picks
Editor's picks
Americas
14 April 2020 The US International Trade Commission is investigating ‘grey market’ in vitro fertilisation products intended for the Turkish market, following a trademark complaint from German pharmaceutical company Merck KGaA.
Americas
23 July 2019 Merck KGaA-owned Sigma-Aldrich has petitioned the US Patent and Trademark Office to open an interference proceeding between its own pending CRISPR-Cas9 patents and patents awarded to the University of California, Berkeley.
Big Pharma
21 November 2019 A German individual has lost an appeal before the tribunal of the EU General Court, after his trademark registration was opposed by Merck.
Americas
14 April 2020 The US International Trade Commission is investigating ‘grey market’ in vitro fertilisation products intended for the Turkish market, following a trademark complaint from German pharmaceutical company Merck KGaA.
Americas
23 July 2019 Merck KGaA-owned Sigma-Aldrich has petitioned the US Patent and Trademark Office to open an interference proceeding between its own pending CRISPR-Cas9 patents and patents awarded to the University of California, Berkeley.
Big Pharma
21 November 2019 A German individual has lost an appeal before the tribunal of the EU General Court, after his trademark registration was opposed by Merck.